Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Sang Kim

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Cancer Research and Treatment|April 28, 2020
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal CancerJwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2013
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerSeungtaek Lim, Byoung Chul Cho, Ji Ye Jung, et al.
Frontiers in Oncology|February 4, 2021
Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score AnalysisJii Bum Lee, Han Sang Kim, Ahrong Ham, et al.
Genome Research|January 13, 2018
Targeting mutant <i>KRAS</i> with CRISPR-Cas9 controls tumor growthWonjoo Kim, Sangeun Lee, Han Sang Kim, et al.
Trials|April 9, 2020
Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trialJii Bum Lee, Han Sang Kim, Inkyung Jung, et al.
Cancer Medicine|July 11, 2019
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablationChang Gon Kim, Hyun Woong Lee, Hye Jin Choi, et al.
STAR Protocols|March 31, 2021
Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluidsLinda Bojmar, Han Sang Kim, Gabriel C Tobias, et al.
Cancer Cell|June 25, 2026
Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growthHilal Bashir, Katherine Z Sanidad, Purnima Ravisankar, et al.
Cancer Research and Treatment|April 28, 2023
ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking GroupShinkyo Yoon, Miso Kim, Yong Sang Hong, et al.
British Journal of Cancer|September 23, 2020
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neckHye Ryun Kim, Han Na Kang, Mi Ran Yun, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Cancer Research and Treatment|April 28, 2020
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal CancerJwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2013
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerSeungtaek Lim, Byoung Chul Cho, Ji Ye Jung, et al.
Frontiers in Oncology|February 4, 2021
Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score AnalysisJii Bum Lee, Han Sang Kim, Ahrong Ham, et al.
Genome Research|January 13, 2018
Targeting mutant <i>KRAS</i> with CRISPR-Cas9 controls tumor growthWonjoo Kim, Sangeun Lee, Han Sang Kim, et al.
Trials|April 9, 2020
Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trialJii Bum Lee, Han Sang Kim, Inkyung Jung, et al.
Cancer Medicine|July 11, 2019
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablationChang Gon Kim, Hyun Woong Lee, Hye Jin Choi, et al.
STAR Protocols|March 31, 2021
Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluidsLinda Bojmar, Han Sang Kim, Gabriel C Tobias, et al.
Cancer Cell|June 25, 2026
Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growthHilal Bashir, Katherine Z Sanidad, Purnima Ravisankar, et al.
Cancer Research and Treatment|April 28, 2023
ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking GroupShinkyo Yoon, Miso Kim, Yong Sang Hong, et al.
British Journal of Cancer|September 23, 2020
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neckHye Ryun Kim, Han Na Kang, Mi Ran Yun, et al.
Pageof 10